Loading clinical trials...
Loading clinical trials...
Generation of Patient Derived Pancreatic Cancer Cell Lines to Determine Mechanisms of Chemoresistance
Conditions
Interventions
Laboratory Biomarker Analysis
Cytology Specimen Collection Procedure
Locations
1
United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Start Date
December 12, 2013
Primary Completion Date
December 15, 2016
Completion Date
December 15, 2016
Last Updated
May 2, 2025
NCT02600949
NCT06921928
NCT06423326
NCT07542041
NCT06821997
NCT07076121
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions